Transcatheter mitral valve in ring, hazards of long anterior mitral leaflet and 3-dimensional rings.

Autor: Sekaran N; Intermountain Heart Institute, Salt Lake City, Utah., Horne BD; Intermountain Heart Institute, Salt Lake City, Utah.; Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, California., Doty JR; Intermountain Heart Institute, Salt Lake City, Utah., Reid BB; Intermountain Heart Institute, Salt Lake City, Utah., Miner EC; Intermountain Heart Institute, Salt Lake City, Utah., Harkness JR; Intermountain Heart Institute, Salt Lake City, Utah., Jones KW; Intermountain Heart Institute, Salt Lake City, Utah., Minder CM; Intermountain Heart Institute, Salt Lake City, Utah., Caine WT; Intermountain Heart Institute, Salt Lake City, Utah., Clayson SE; Intermountain Heart Institute, Salt Lake City, Utah., Whisenant BK; Intermountain Heart Institute, Salt Lake City, Utah.
Jazyk: angličtina
Zdroj: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2021 Feb 01; Vol. 97 (2), pp. 353-358. Date of Electronic Publication: 2020 Aug 31.
DOI: 10.1002/ccd.29232
Abstrakt: Objectives: The purpose of this study was to define anterior mitral leaflet (AML) length and mitral ring characteristics associated with LVOT obstruction and PVL following MViR.
Background: Transcatheter Mitral Valve in Ring (MViR) procedural complications including parvalvular leak (PVL) and left ventricular outflow tract (LVOT) obstruction are frequent.
Methods: Clinical records, computer tomographic scans (CTs) and echocardiograms of consecutive MViR patients were retrospectively reviewed for anterior mitral leaflet length, CT-simulated neoLVOT, and aortomitral angle among patients with and without MViR-induced LVOT obstruction. Acute and 1-year outcomes are described.
Results: Twenty-two patients underwent MViR. Technical success was achieved in 13/22 (57.1%) patients, limited by paravalvular regurgitation requiring second transcatheter heart valves (THVs) in seven patients. Second valves were needed in 6/11 (54.5%) patients with 3-dimensional rings but 1/11 (9.1%, p = .06) of patients with planar rings. Procedure success at 30 days was achieved in 20/22 (90.9%) patients. There were no procedural, in-hospital, or 30-day deaths. Two patients developed significant LVOT obstruction, one managed with urgent surgery and one with elective alcohol septal ablation. Anterior mitral leaflets were longer among the two patients with LVOT obstruction than the 20 patients who did not develop LVOT obstruction when measured by TEE (30 mm vs. 21 mm, p = .009) or by CT (29 mm vs. 22 mm, p = .026).
Conclusions: AML >25 mm increases the risk of MViR induced LVOT obstruction. PVL is common, particularly in 3-dimensional rings which can be managed with a second THV.
(© 2020 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: